Nitric oxide, advanced glycation end products, and uremia

This publication has 9 references indexed in Scilit:

• Nitric oxide inhibits the formation of advanced glycation end products
  Kidney International, 2000
• Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients
  Journal of Clinical Investigation, 2000
• Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications
  Kidney International, 1999
• Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product
  Journal of the American Society of Nephrology, 1998
• Physiology and biochemistry of endothelial function in children with chronic renal failure
  Kidney International, 1997
• Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin.
  Proceedings of the National Academy of Sciences, 1992
• Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
  Journal of Clinical Investigation, 1991
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988